Procyon Stock Today
| PCYN Stock | USD 0.12 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressSmall
|
Procyon is selling at 0.12 as of the 2nd of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 0.12. Procyon has about a 33 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 3rd of December 2025 and ending today, the 2nd of January 2026. Click here to learn more.
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. The company was incorporated in 1987 and is based in Oldsmar, Florida. The company has 8.09 M outstanding shares. More on Procyon
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Procyon Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Procyon [PCYN] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Procyon's market, we take the total number of its shares issued and multiply it by Procyon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Procyon conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 8.09 M outstanding shares.
Procyon currently holds about 1.04 M in cash with (229.46 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Procyon Probability Of Bankruptcy
Ownership AllocationProcyon holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.0 pct. of Procyon outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Check Procyon Ownership Details
Procyon Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Procyon without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Other Information on Investing in Procyon Pink Sheet
Procyon financial ratios help investors to determine whether Procyon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procyon with respect to the benefits of owning Procyon security.